Alkylamides from Echinacea Modulate Induced Immune Responses in Macrophages

REFERENCES

• Agnew L. L., Guffogg S. P., Matthias A., Lehmann R. P., Bone K. M., Watson K. Echinacea intake induces an immune response through altered expression of leukocyte hsp70, increased white cell counts and improved erythrocyte antioxidant defences. J. Clin. Pharm. Therap 2005; 30: 363–369
   PubMed Web of Science ®Google Scholar
• Aktan F., Henness S., Roufogalis B. D., Ammit A. J. Gypenosides derived from Gynostemma pentaphyllum suppress NO synthesis in murine macrophages by inhibiting iNOS enzymatic activity and attenuating NF- κB-mediated iNOS protein expression. Nitric Oxide 2003; 8: 235–242
   PubMed Web of Science ®Google Scholar
• Bauer R., Jurcic K., Puhlmann J., Wagner H. Immunologische In-vivo und In‐vitro-Untersuchungen mit Echinacea-Extrakten. Arzneimittelforschung 1988; 38: 276–281
   PubMed Web of Science ®Google Scholar
• Bender J. G., McPhail L. C., van Epps D. E. Exposure of human neutrophils to chemotactic factors potentiates activation of the respiratory burst enzyme. J. Immunol 1983; 130: 2316–2323
   PubMed Web of Science ®Google Scholar
• Binns S. E., Livesey J. F., Arnason J. T., Baum B. R. Phytochemical variation in Echinacea from roots and flowerheads of cultivated populations. J. Agri. Food Chem 2002; 50: 3673–3687
   PubMed Web of Science ®Google Scholar
• Bodinet C., Willigmann I., Beuscher N. Host-resistance increasing activity of root extracts from Echinacea species. Planta Med 1993; 59: A672–673
   Google Scholar
• Currier N. L., Miller S. C. Natural killer cells from aging mice treated with extracts from Echinacea purpurea are quantitatively and functionally rejuvenated. Exper. Gerontol 2000; 35: 627–639
   PubMed Web of Science ®Google Scholar
• Felter H. W., Lloyd J. U. Echinacea. King's American Dispensatory 18th, 3rd revision. First published 1905, reprinted Eclectic Medical Publications, Portland 1905; 1: 671–677
   Google Scholar
• Forman H. J., Torres M. Redox signalling in macrophages. Mol. Aspects of Med 2001; 22: 189–216
   PubMedGoogle Scholar
• Gertsch J., Schoop R., Kuenzle U., Suter A. Echinacea alkylamides modulate TNF-α gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways. FEBS Lett 2004; 577: 563–569
   PubMed Web of Science ®Google Scholar
• Goel V., Chang C., Slama J., Barton R., Bauer R., Gahler R., Basu T. K. Echinacea stimulates macrophage function in the lung and spleen of normal rats. J. Nutr. Biochem 2002; 13: 487–492
   PubMed Web of Science ®Google Scholar
• Hobbs A. J., Higgs A., Moncada S. Inhibition of nitric oxide synthase as a potential therapeutic agent. Annu. Rev. Pharmacol. Toxicol 1999; 39: 191–220
   PubMed Web of Science ®Google Scholar
• Kitchens R. L., Munford R. S. Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J. Biol. Chem 1995; 270: 9904–9910
   PubMed Web of Science ®Google Scholar
• Komatsu H., Tsukimori K., Hata K., Satoh S., Nakano H. The characterization of superoxide production of human neonatal neutrophil. Early Human Devel 2001; 65: 11–19
   PubMed Web of Science ®Google Scholar
• Kuo C. T., Chiang L. L., Lee C. N., Yu M. C., Bai K. J., Lee H. M., Lee W. S., Sheu J. R., Lin C. H. Induction of nitric oxide synthase in RAW 264.7 macrophages by lipoteichoic acid from Staphylococcus aureus: involvement of protein kinase-C and nuclear factor-kB-dependent mechanisms. J. Biomed. Sci 2003; 10: 136–145
   PubMed Web of Science ®Google Scholar
• Lentner C. Geigy Scientific Tables. Ciba-Geigy, BaselSwitzerland 2003; volume 3: 65
   Google Scholar
• Matthias A., Addison R. S., Penman K. G., Dickinson R. G., Bone K. M., Lehmann R. P. Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion. Life Sci 2005; 77: 2018–2029
   PubMed Web of Science ®Google Scholar
• Matthias A., Blanchfield J. T., Penman K. G., Toth I., Lang C.-S., De Voss J. J., Lehmann R. P. Permeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco-2 cell monolayer model. J. Clin. Pharm. Therap 2004; 29: 7–13
   PubMed Web of Science ®Google Scholar
• Randolph R. K., Gellenbeck K., Stonebrook K., Brovelli E., Qian Y., Bankaitis-Davis D., Cheronis J. Regulation of human immune gene expression as influenced by a commercial blended Echinacea product: preliminary studies. Exp. Biol. Med 2003; 228: 1051–1056
   Web of Science ®Google Scholar
• Rinninger J. A., Kickner S., Chigurupati P., McLean A., Franck Z. Immunopharmacological activity of Echinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cells. J. Leuk. Biol 2000; 68: 503–510
   PubMed Web of Science ®Google Scholar
• Sun L. Z. Y., Currier N. L., Miller S. C. The American coneflower: a prophylactic role involving nonspecific immunity. J. Altern. Compl. Med 1999; 5: 437–446
   PubMed Web of Science ®Google Scholar
• Wang Y., Marsden P. A. Nitric oxide synthases: gene structure and regulation. Adv. Pharmacol 1995; 34: 71–90
   PubMedGoogle Scholar
• Woelkart K., Koidl C., Grisold A., Gangemi J. D., Turner R. B., Marth E., Bauer R. Bioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humans. J. Clin. Pharmacol 2005; 45: 683–689
   PubMed Web of Science ®Google Scholar